FDA Approved: ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approved a supplemental application for ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE from Glenmark Pharmaceuticals Inc., USA, authorizing this generic combinati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke
• Transient Ischemic Attack

Drugs mentioned

• ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE (aspirin and extended-release dipyridamole)

Snippet

SUPPL AP for ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE (ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE)